Iambic Raises $150M in IPO to Push AI-Designed Cancer Drugs
The AI biotech prices its Nasdaq debut at $16 a share
Your likes
Saved in this browser. Log in to your AI Parabellum account to keep them on every device.
Tap the heart on any tool or article and it will be saved here for later.
The AI biotech prices its Nasdaq debut at $16 a share
States say OpenAI oversold safety and put young users at risk
AI agents wrote the code for Epic's faster, Linux-ready launcher
The AI scribe maker wants agents to handle paperwork after visits
Accel leads a round that triples the AI cloud startup's value
Alibaba's models get the nod, but Siri AI stays out for now
Voting answers, live results, and tougher misuse detection
A faster speech model aimed at support calls and car assistants
A new tag shows when AI wrote or sang a big part of a track
A new filing flips the trade secrets fight between the two giants
An open-source fix for forecast errors that runs on ordinary CPUs
Gemini now reads the intent behind suspicious texts
An AI messenger built for shift workers, not desk jobs
A new toggle keeps fully AI-made songs out of your searches
Five years of compute for AI agent safety, plus a $2B Europe push
An AI agent that builds and watches trips from your inbox
Small language models check every AI prompt in milliseconds
Court fast-tracks evidence tied to OpenAI's first device
Newsletter
New AI tools in your inbox
The best new tools and the AI news that matters, in one short email. Unsubscribe any time.
Free · No spam · Unsubscribe any time
✓ Looks like you’re subscribed
Free instant check before you pay. Takes a few seconds.
Paste your tool address below and we will confirm it meets our content standards.
We only read the public content of the page you enter.
Preparing your check
This usually takes five to fifteen seconds.